Takashi Imada

544 total citations
9 papers, 242 citations indexed

About

Takashi Imada is a scholar working on Molecular Biology, Organic Chemistry and Reproductive Medicine. According to data from OpenAlex, Takashi Imada has authored 9 papers receiving a total of 242 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Organic Chemistry and 2 papers in Reproductive Medicine. Recurrent topics in Takashi Imada's work include Cancer therapeutics and mechanisms (2 papers), Hypothalamic control of reproductive hormones (2 papers) and Synthesis and biological activity (2 papers). Takashi Imada is often cited by papers focused on Cancer therapeutics and mechanisms (2 papers), Hypothalamic control of reproductive hormones (2 papers) and Synthesis and biological activity (2 papers). Takashi Imada collaborates with scholars based in Japan and United States. Takashi Imada's co-authors include Nobuo Cho, Masataka Harada, Nobuhiro Suzuki, Satoshi Endo, Shuichi Furuya, Toshihiro Imaeda, Yoji Hayase, Hirokazu Matsumoto, Satoshi Sasaki and Kazuhiro Ogi and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Takashi Imada

9 papers receiving 232 citations

Peers

Takashi Imada
Maria F. Palafox United States
Dongpei Wu United States
F Gaillard France
Takashi Imada
Citations per year, relative to Takashi Imada Takashi Imada (= 1×) peers Raquel Garcı́a-Nieto

Countries citing papers authored by Takashi Imada

Since Specialization
Citations

This map shows the geographic impact of Takashi Imada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Imada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Imada more than expected).

Fields of papers citing papers by Takashi Imada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Imada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Imada. The network helps show where Takashi Imada may publish in the future.

Co-authorship network of co-authors of Takashi Imada

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Imada. A scholar is included among the top collaborators of Takashi Imada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Imada. Takashi Imada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kurasawa, Osamu, T. Miyazaki, Misaki Homma, et al.. (2020). Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent. Journal of Medicinal Chemistry. 63(3). 1084–1104. 16 indexed citations
2.
Hitaka, Takenori, Takashi Imada, Masami Yamada, et al.. (2017). Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: Optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives. Bioorganic & Medicinal Chemistry Letters. 27(9). 1897–1901. 15 indexed citations
3.
Hirayama, Takaharu, Masanori Okaniwa, Takashi Imada, et al.. (2013). Synthetic studies of centromere-associated protein-E (CENP-E) inhibitors: 1.Exploration of fused bicyclic core scaffolds using electrostatic potential map. Bioorganic & Medicinal Chemistry. 21(17). 5488–5502. 20 indexed citations
4.
Okaniwa, Masanori, Takashi Imada, Tomohiro Ohashi, et al.. (2012). Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 2. Synthesis and characterization of a novel imide-type prodrug for improving oral absorption. Bioorganic & Medicinal Chemistry. 20(15). 4680–4692. 8 indexed citations
5.
Hirose, Masaaki, Masanori Okaniwa, T. Miyazaki, et al.. (2012). Design and synthesis of novel DFG-out RAF/vascular endothelial growth factor receptor 2 (VEGFR2) inhibitors: 3. Evaluation of 5-amino-linked thiazolo[5,4-d]pyrimidine and thiazolo[5,4-b]pyridine derivatives. Bioorganic & Medicinal Chemistry. 20(18). 5600–5615. 12 indexed citations
7.
Cho, Nobuo, Masataka Harada, Toshihiro Imaeda, et al.. (1998). Discovery of a Novel, Potent, and Orally Active Nonpeptide Antagonist of the Human Luteinizing Hormone-Releasing Hormone (LHRH) Receptor. Journal of Medicinal Chemistry. 41(22). 4190–4195. 106 indexed citations
8.
Kikuchi, Takashi, Tetsuya Ohtaki, Takashi Imada, et al.. (1994). Cyclic Hexapeptide Endothelin Receptor Antagonists Highly Potent for Both Receptor Subtypes ETA and ETB. Biochemical and Biophysical Research Communications. 200(3). 1708–1712. 38 indexed citations
9.
Endo, Yasuyuki, Takashi Imada, Kentaro Yamaguchi, & Koichi Shudo. (1994). Conformational States of Indolacrams. Structures of 13-N-Desmethylidolactam-V and 13-O-Indolactam-V. Heterocycles. 39(2). 571–571. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026